Literature DB >> 1865419

The fibromyalgia impact questionnaire: development and validation.

C S Burckhardt1, S R Clark, R M Bennett.   

Abstract

An instrument has been developed to assess the current health status of women with the fibromyalgia syndrome. The Fibromyalgia Impact Questionnaire (FIQ) is a brief 10-item, self-administered instrument that measures physical functioning, work status, depression, anxiety, sleep, pain, stiffness, fatigue, and well being. We describe its development and validation. This initial assessment indicates that the FIQ has sufficient evidence of reliability and validity to warrant further testing in both research and clinical situations.

Entities:  

Mesh：

Year:  1991        PMID： 1865419

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  454 in total

Review 1.  The treatment of fibromyalgia: a review of clinical trials.

Authors:  L J Crofford; B E Appleton
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

2.  The frequency of hypermobility and its relationship with clinical findings of fibromyalgia patients.

Authors:  O Faruk Sendur; Gulcan Gurer; Gulnur Tasci Bozbas
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

3.  Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

Authors:  O Zachrisson; P Colque-Navarro; C G Gottfries; B Regland; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-20       Impact factor: 3.267

Review 4.  Massage therapy for fibromyalgia symptoms.

Authors:  Leonid Kalichman
Journal:  Rheumatol Int       Date:  2010-03-20       Impact factor: 2.631

5.  Efficacy of anodal transcranial direct current stimulation (tDCS) for the treatment of fibromyalgia: results of a randomized, sham-controlled longitudinal clinical trial.

Authors:  Angela Valle; Suely Roizenblatt; Sueli Botte; Soroush Zaghi; Marcelo Riberto; Sergio Tufik; Paulo S Boggio; Felipe Fregni
Journal:  J Pain Manag       Date:  2009

6.  The development and psychometric validation of the central sensitization inventory.

Authors:  Tom G Mayer; Randy Neblett; Howard Cohen; Krista J Howard; Yun H Choi; Mark J Williams; Yoheli Perez; Robert J Gatchel
Journal:  Pain Pract       Date:  2011-09-27       Impact factor: 3.183

7.  Are there differences in quality of life, symptomatology and functional capacity among different obesity classes in women with fibromyalgia? The al-Ándalus project.

Authors:  V A Aparicio; V Segura-Jiménez; I C Alvarez-Gallardo; F Estévez-López; D Camiletti-Moirón; P A Latorre; M Delgado-Fernández; A Carbonell-Baeza
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

8.  Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity.

Authors:  Sema Haliloglu; Ayse Carlioglu; Derya Akdeniz; Yasar Karaaslan; Ali Kosar
Journal:  Rheumatol Int       Date:  2014-03-04       Impact factor: 2.631

9.  Low-level laser therapy to treat fibromyalgia.

Authors:  J A Ruaro; A R Fréz; M B Ruaro; R A Nicolau
Journal:  Lasers Med Sci       Date:  2014-05-07       Impact factor: 3.161

10.  Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial.

Authors:  Jeong Lan Kim; Shilpa Rele; David M Marks; Prakash S Masand; Pallavi Yerramsetty; Robert A Millet; Richard S Keefe; Ashwin A Patkar
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.